Yara Alyahyawi: Advancing Epigenetic Therapy for Hemophilia B
Yara Alyahyawi, Assistant Professor at Jazan University and PhD researcher at University of Birmingham, shared a post on LinkedIn about a recent article she and T. M. Belali co-authored, published in Molecular Biology, adding:
“Thank God, our scientific paper entitled
Epigenetic Reactivation of F9 via HNF4α as a Therapeutic Strategy for Hemophilia B
Using the In Silico model, the research explores the possibility of enhancing F9 gene expression through HNF4α and CRISPR-based epigenetic activation as a promising research strategy for Hemophilia B.
I was honored to be the first author and corresponding author in this work.”
Title: Epigenetic Reactivation of F9 via HNF4α as a Therapeutic Strategy for Hemophilia B
Authors: Y. Alyahyawia, and T. M. Belali
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 10, 2026, 10:23Stephen Brown: Help Us Shape The Future of Hemophilia A Care
-
Jul 10, 2026, 09:57Katherine Rozycki: The Future of Haematology Through Education
-
Jul 10, 2026, 09:42Biljana Andrić: The Best Transfusion Is Often The One That Can Be Avoided
-
Jul 10, 2026, 09:27Farnaz Poorhasan: FFP is More Than Just Frozen Blood Components
-
Jul 10, 2026, 02:32Nina Laue: Looking Forward to Connecting and Collaborating at ISTH 2026
-
Jul 10, 2026, 02:19Anita Singla: Thalassemia Screening in Pregnancy Has a Lifelong Impact
-
Jul 10, 2026, 02:07Ruman Bashir: Immune Thrombocytopenia in Pregnancy
-
Jul 9, 2026, 19:20Bradley Maron: The Beginning of a New Chapter for Circulation
-
Jul 9, 2026, 19:00Wolfgang Miesbach: ISTH 2026 Showcases the Future of Gene Therapy